Trial intelligence / Profile preview

PRGF-Endoret in Alveolar Ridge Preservation

NCT04093583Phase 3Completed

Sponsor
Fundación Eduardo Anitua
Start
Nov 2019
Primary completion
Jan 2025
Modality
Cell Therapies
Countries
1
01

Overview

A Phase 3 trial of PRGF-Endoret in Alveolar ridge resorption, sponsored by Fundación Eduardo Anitua. Started Nov 2019; status: completed.

02

Drugs

PRGF-Endoret
03

Conditions

Alveolar ridge resorption

Beyond the preview

Go deeper on NCT04093583.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04093583.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call